EMC Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11K Buy
+278
New +$8.85K ﹤0.01% 50
2025
Q4
$8K Hold
278
﹤0.01% 297
2025
Q3
$8K Sell
278
-79
-22% -$2K ﹤0.01% 300
2025
Q2
$9K Hold
357
﹤0.01% 294
2025
Q1
$7K Hold
357
﹤0.01% 281
2024
Q4
$8K Sell
357
-13,732
-97% -$338K ﹤0.01% 278
2024
Q3
$129K Buy
14,089
+13,732
+3,846% +$350K 0.08% 206
2024
Q2
$8K Hold
357
﹤0.01% 269
2024
Q1
$10K Sell
357
-30
-8% -$902 0.01% 272
2023
Q4
$13K Hold
387
0.01% 268
2023
Q3
$11K Sell
387
-6,535
-94% -$214K 0.01% 278
2023
Q2
$78 Buy
6,922
+5,035
+267% +$158K 0.06% 235
2023
Q1
$56K Hold
1,887
0.05% 250
2022
Q4
$53K Hold
1,887
0.05% 256
2022
Q3
$66K Buy
1,887
+1,500
+388% +$55.1K 0.06% 232
2022
Q2
$14K Hold
387
0.01% 291
2022
Q1
$18K Sell
387
-30,918
-99% -$1.47M 0.01% 312
2021
Q4
$1.92M Sell
31,305
-179
-0.6% -$12.4K 1.03% 18
2021
Q3
$2.36M Sell
31,484
-15,000
-32% -$1.26M 1.32% 11
2021
Q2
$4.04M Buy
46,484
+67
+0.1% +$5.7K 2.29% 6
2021
Q1
$4.12M Buy
46,417
+114
+0.2% +$11.3K 2.93% 4
2020
Q4
$4.32M Buy
+46,303
New +$3.69M 3.29% 4

Other funds holding ARKG

EMC Capital Management's ARKG Position: Q2 2026 in Review

EMC Capital Management opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 278 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #50 among its holdings. This is a return to the name: EMC Capital Management previously reported a position in ARKG as recently as Q4 2025.

EMC Capital Management first reported a position in ARKG in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.32M in Q4 2020. 104 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • EMC Capital Management held 278 shares of ARK Genomic Revolution ETF worth $11K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new EMC Capital Management position in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of EMC Capital Management's portfolio in Q2 2026, its #50 holding.
  • EMC Capital Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 22 quarters since.
  • EMC Capital Management's ARK Genomic Revolution ETF position peaked at $4.32M in Q4 2020.
  • 104 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on EMC Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.